HB 1418: Drug Price Transparency

HB 1418: Drug Price Transparency

Relative to Transparency and Cost Control Of Pharmaceutical Drug Prices.

New Futures supports this bill, as it creates a commission which would look at drug price transparency and rebates for pharmaceutical benefit managers. New Futures supports this bill because it would shine a light on the costs of drugs so that the state and, in turn, the public can better understand the increasing costs of pharmaceuticals.

Click here for bill text.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote